Enter assignee name

Forward Citations = 2

Loading Chart...

13 inventors (with patents filed for the assignee):

Dennis M Brown (6 out of 29 patents)

Jeffrey A Bacha (6 out of 8 patents)

Anne Steinø (3 out of 4 patents)

4. Sandra Dunn (2 out of 6 patents)

5. Kent C Shih (1 out of 1 patent)

6. Anne Steino (1 out of 1 patent)

7. Richard Schwartz (1 out of 1 patent)

8. Sarath Kanekal (1 out of 1 patent)

9. Howard A Burris, Iii (1 out of 1 patent)

10. Shaun Fouse (1 out of 1 patent)

11. Qiang Xu (1 out of 1 patent)

12. Xiaoyun Liu (1 out of 2 patents)

13. William J Garner (1 out of 17 patents)

8 patents: Sort by Forward Citations

1. 11717505 - Dianhydrogalactitol for the treatment of diffuse intrinsic pontine gliomas (2023-08-08),

2. 11541027 - Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases (2023-01-03),

3. 11446274 - Use of dianhydrogalactitol or derivatives or analogs thereof for treatment of pediatric central nervous system malignancies (2022-09-20),

4. 11234955 - Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma (2022-02-01),

5. 11026914 - Use of dianhydrogalactitol and analogs and derivatives thereof to treat recurrent malignant glioma or progressive secondary brain tumor (2021-06-08),

6. 10591445 - Methods for analysis and resolution of preparations of dianhydrogalactitol and derivatives or analogs thereof (2020-03-17),

7. 10201521 - Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma (2019-02-12),

8. 10145824 - Analytical methods for analyzing and determining impurities in dianhydrogalactitol (2018-12-04),

Del Mar Pharmaceuticals (bc) Ltd. is a biopharmaceutical company dedicated to developing and commercializing novel cancer therapies. Our lead product candidate, VAL-083, is a potential treatment for a range of cancers, including glioblastoma, ovarian, and lung cancer. We are committed to advancing innovative therapies that address unmet medical needs and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#111 in Vancouver

#1,805 in Canada

Vancouver, Canada

Del Mar Pharmaceuticals (bc) Ltd.